argenx
Developing antibody-based medicines
- B2B
About argenx
Global immunology company focused on developing novel antibody-based medicines for severe autoimmune diseases through collaborations with leading researchers
Key facts
- Industry
- Biotechnology Research
- Company size
- 1,001–5,000 employees
- Headquarters
- boston, massachusetts, United States
- Founded
- 2008
- Revenue
- $4.2BFY2025, publicly reported
- Website
- argenx.com
- linkedin.com/company/argenx
argenx at a glance
argenx is a B2B company in the Biotechnology Research industry, headquartered in boston, massachusetts, United States.
argenx was founded in 2008.
argenx has 1,001–5,000 employees.
argenx's revenue is $4.2B (FY2025, publicly reported).
Selling to companies like argenx?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies